Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global Animal Model Substitutes market size was valued at USD 1519.62 million in 2022 and is expected to expand at a CAGR of 5.81% during the forecast period, reaching USD 2132.53 million by 2028.
Animal model substitutes use artificially cultured cells or tissue lines, or microfluidic on-chip organ systems, rather than live animals. Generally, animals such as mice are not accurate models for human drugs. It is generally agreed that reducing the number of animals used and improving testing to reduce suffering should be important goals for the industries involved. As with traditional toxicology research, research using alternative models is for the ultimate benefit of human health, environmental health and/or the health and well-being of the test species itself.
Influence of COVID-19 Outbreak on Animal Model Substitutes Industry Development
The animal model substitute industry is an industry under the pressure of COVID-19. As people self-isolate at home, many experimental research activities have to be cancelled.
The key point here is that the impact of COVID-19 on the industry may vary greatly from product to product and service to service in different industries. Indeed, the company reported negative trends in one aspect of its business, while reporting positive trends in other areas. Some indicators have decreased, while others have increased unexpectedly.
One of the most frustrating effects of the spread of COVID-19 is the disruption to the supply chain. Although the research and production of animal model substitutes are being carried out at the same time, they will inevitably be affected by the epidemic. This is mainly reflected in the fact that R&D personnel will be isolated at home for personal safety, and the raw materials used for production will be affected by transportation interruptions.
Drivers
Non-animal testing market technologies are being developed to reduce the use of animals, fast track the drug development process and develop costeffective methods. These alternatives to animal testing market technology are receiving increasing attention.
Protests by animal welfare organizations (such as Animal Ethical Treatment of People (PETA) and International Cruelty International) have put tremendous pressure on federal agencies and companies that perform animal testing. They must reduce or eliminate the animal testing market and use alternative animals. Test method (if applicable).
Because testing of alternatives to animal models is cost-effective, more efficient, and often time-saving. Protests by animal welfare organizations (such as Animal Ethical Treatment of People (PETA) and International Cruelty International) have put tremendous pressure on federal agencies and companies that perform animal testing. They must reduce or eliminate the animal testing market and use alternative animals. Test method (if applicable).
The pharmaceutical industry is increasingly inclined to adopt alternative methods because the industry is committed to increasing productivity and reducing adverse reactions. The implementation of a series of extremely strict sales bans on animal testing reflects the consistency of technology (stem cells, imaging) and social development (environmental issues, consumer influence), and ultimately affects the use of animal testing in the cosmetics industry and the pharmaceutical industry.
Region Overview:
From 2023-2028, Europe is estimated to witness robust growth prospects.
Company Overview:
BioIVT is one of the major players operating in the Animal Model Substitutes market, holding a share of 3.7% in 2021.
BioIVT, formerly BioreclamationIVT, is the world's leading provider of high-quality biological specimens and value-added services. The company focuses on samples for control and disease states, including human and animal tissues, cell products, blood and other biological fluids.
Cyprotex is the world's largest contract research organization, specializing in preclinical ADME Tox. Cyprotex provides the most comprehensive ADME Tox CRO service.
Segmentation Overview:
Among different product types, In Vitro testing segment is anticipated to contribute the largest market share in 2028.
Application Overview:
By application, the Research & development segment occupied the biggest share from 2018 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Animal Model Substitutes industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Animal Model Substitutes. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Animal Model Substitutes Market Report Include:
Market Size Estimates: Animal Model Substitutes market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Animal Model Substitutes market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Animal Model Substitutes market
Segment Market Analysis: Animal Model Substitutes market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Animal Model Substitutes market situations and prospects in major and top regions and countries
Animal Model Substitutes Market
Animal Model Substitutes Industry Chain: Animal Model Substitutes market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Animal Model Substitutes Industry News, Policies by regions
Animal Model Substitutes Industry Porters Five Forces Analysis
Key players in the global Animal Model Substitutes market are covered in Chapter 2:
Abzena
Emulate, Inc
MatTek
SGS SA
Nortis Inc.
InSphero
Cyprotex
BioIVT
Mimetas
Others
ReproCell Inc
Tara Biosystems
HuRel Corporation
Episkin
Organovo Holdings, Inc
In Chapter 6 and Chapter 9, on the basis of types, the Animal Model Substitutes market from 2018 to 2028 is primarily split into:
In Vitro testing
In Silico Modeling
Human Volunteers
Stem cell research
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Animal Model Substitutes market from 2018 to 2028 covers:
Research & development
Production and quality control
Academics
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Animal Model Substitutes market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Animal Model Substitutes industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Animal Model Substitutes market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Animal Model Substitutes industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Animal Model Substitutes market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Animal Model Substitutes market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Animal Model Substitutes market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
2022
Animal model substitutes use artificially cultured cells or tissue lines, or microfluidic on-chip organ systems, rather than live animals. Generally, animals such as mice are not accurate models for human drugs. It is generally agreed that reducing the number of animals used and improving testing to reduce suffering should be important goals for the industries involved. As with traditional toxicology research, research using alternative models is for the ultimate benefit of human health, environmental health and/or the health and well-being of the test species itself.
Influence of COVID-19 Outbreak on Animal Model Substitutes Industry Development
The animal model substitute industry is an industry under the pressure of COVID-19. As people self-isolate at home, many experimental research activities have to be cancelled.
The key point here is that the impact of COVID-19 on the industry may vary greatly from product to product and service to service in different industries. Indeed, the company reported negative trends in one aspect of its business, while reporting positive trends in other areas. Some indicators have decreased, while others have increased unexpectedly.
One of the most frustrating effects of the spread of COVID-19 is the disruption to the supply chain. Although the research and production of animal model substitutes are being carried out at the same time, they will inevitably be affected by the epidemic. This is mainly reflected in the fact that R&D personnel will be isolated at home for personal safety, and the raw materials used for production will be affected by transportation interruptions.
Drivers
Non-animal testing market technologies are being developed to reduce the use of animals, fast track the drug development process and develop costeffective methods. These alternatives to animal testing market technology are receiving increasing attention.
Protests by animal welfare organizations (such as Animal Ethical Treatment of People (PETA) and International Cruelty International) have put tremendous pressure on federal agencies and companies that perform animal testing. They must reduce or eliminate the animal testing market and use alternative animals. Test method (if applicable).
Because testing of alternatives to animal models is cost-effective, more efficient, and often time-saving. Protests by animal welfare organizations (such as Animal Ethical Treatment of People (PETA) and International Cruelty International) have put tremendous pressure on federal agencies and companies that perform animal testing. They must reduce or eliminate the animal testing market and use alternative animals. Test method (if applicable).
The pharmaceutical industry is increasingly inclined to adopt alternative methods because the industry is committed to increasing productivity and reducing adverse reactions. The implementation of a series of extremely strict sales bans on animal testing reflects the consistency of technology (stem cells, imaging) and social development (environmental issues, consumer influence), and ultimately affects the use of animal testing in the cosmetics industry and the pharmaceutical industry.
Region Overview:
From 2023-2028, Europe is estimated to witness robust growth prospects.
Company Overview:
BioIVT is one of the major players operating in the Animal Model Substitutes market, holding a share of 3.7% in 2021.
BioIVT, formerly BioreclamationIVT, is the world's leading provider of high-quality biological specimens and value-added services. The company focuses on samples for control and disease states, including human and animal tissues, cell products, blood and other biological fluids.
Cyprotex is the world's largest contract research organization, specializing in preclinical ADME Tox. Cyprotex provides the most comprehensive ADME Tox CRO service.
Segmentation Overview:
Among different product types, In Vitro testing segment is anticipated to contribute the largest market share in 2028.
Application Overview:
By application, the Research & development segment occupied the biggest share from 2018 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Animal Model Substitutes industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Animal Model Substitutes. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Animal Model Substitutes Market Report Include:
Market Size Estimates: Animal Model Substitutes market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Animal Model Substitutes market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Animal Model Substitutes market
Segment Market Analysis: Animal Model Substitutes market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Animal Model Substitutes market situations and prospects in major and top regions and countries
Animal Model Substitutes Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.Animal Model Substitutes Industry Chain: Animal Model Substitutes market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Animal Model Substitutes Industry News, Policies by regions
Animal Model Substitutes Industry Porters Five Forces Analysis
Key players in the global Animal Model Substitutes market are covered in Chapter 2:
Abzena
Emulate, Inc
MatTek
SGS SA
Nortis Inc.
InSphero
Cyprotex
BioIVT
Mimetas
Others
ReproCell Inc
Tara Biosystems
HuRel Corporation
Episkin
Organovo Holdings, Inc
In Chapter 6 and Chapter 9, on the basis of types, the Animal Model Substitutes market from 2018 to 2028 is primarily split into:
In Vitro testing
In Silico Modeling
Human Volunteers
Stem cell research
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Animal Model Substitutes market from 2018 to 2028 covers:
Research & development
Production and quality control
Academics
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Animal Model Substitutes market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Animal Model Substitutes industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Animal Model Substitutes market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Animal Model Substitutes industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Animal Model Substitutes market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Animal Model Substitutes market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Animal Model Substitutes market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
